The Company intends to use the net proceeds from the Private Placement for working capital and general corporate purposes. The Private Placement is subject to certain closing conditions, including, but not limited to, the receipt of all necessary regulatory approvals and the approval of the TSX Venture Exchange (the "TSXV"). The Private Placement will be made to qualified investors in such provinces of Canada as the Company may designate, and otherwise in those jurisdictions where the Private Placement can ...

Core Points - Permex Petroleum Corporation has successfully closed a private placement of convertible debenture units, raising gross proceeds of US$2,000,000 [1][2] Group 1: Offering Details - The Offering consisted of 2,000 Units, each comprising one convertible debenture with a principal amount of US$1,000 and 393 common share purchase warrants [2] - The Debentures will mature one year from the issuance date and bear simple interest at a rate of 10%, payable on the Maturity Date or upon repayment [3] - Holders of the Debentures can convert the principal and accrued interest into Shares at a conversion price of US$2.54, subject to certain conditions [4] Group 2: Use of Proceeds - The proceeds from the Offering are intended for general working capital purposes [5] Group 3: Subscriber Information - Kent Lindemuth acquired all 2,000 Units for a total consideration of US$2,000,000, increasing his ownership in the company to 81.71% of the issued and outstanding Shares on a partially-diluted basis [10] Group 4: Company Overview - Permex Petroleum is a junior oil and gas company with operations in the Permian Basin of West Texas and the Delaware Sub-Basin of New Mexico, focusing on low-cost development and sustainable growth [12]

Core Points - Terra Balcanica Resources Corp. has closed the first tranche of its private placement, raising gross proceeds of C$814,914 through the issuance of 8,149,141 units at a price of C$0.10 per unit [1] - The company is extending the final closing date of the private placement to raise total gross proceeds of up to C$1,117,495 by August 11, 2025 [2] - The President and CEO of the company, Aleksandar Mišković, highlighted significant participation from Dundee Corporation, indicating strong interest in the company's work [3] - The company is exercising its option to acquire a 100% interest in several uranium licence clusters from Fulcrum Metals, involving a cash payment of C$50,000 and the issuance of C$350,000 in common shares [5] - Terra Balcanica is focused on large-scale mineral systems in the Balkans and northern Saskatchewan, with a 90% interest in the Viogor-Zanik Project and a 100% optioned portfolio of uranium-prospective licences [7]

Core Viewpoint - Kingman Minerals Ltd. has received approval to extend the deadline for its Annual General Meeting to October 21, 2025, and plans to complete a non-brokered private placement of up to $504,000 [1][6]. Financing Details - The company intends to issue up to 7,200,000 units at a price of $0.07 per unit, with each unit consisting of one common share and one warrant [2]. - Each warrant will allow the holder to purchase an additional common share at an exercise price of $0.09 for 24 months from the closing date of the offering [2]. - Finder's fees of 6.0% of gross proceeds may be paid, along with finder's warrants equal to 6.0% of the units sold [3]. Use of Proceeds - The net proceeds from the offering will be used for working capital and to advance the preparation and permitting of an exploration plan at the Mohave Project, including the historic Rosebud Mine in Arizona [3]. AGM Extension - The company was required to hold its AGM by August 21, 2025, but has received an extension to October 21, 2025, to ensure adequate preparation [6][7]. - This extension allows the company to complete necessary corporate, regulatory, and administrative preparations for the AGM [7]. Related Party Transactions - Certain insiders of the company are expected to acquire units in the offering, which will be considered related party transactions [5]. - The company plans to rely on exemptions from formal valuation and minority shareholder approval requirements due to the fair market value of related party participation being below 25% of its market capitalization [5]. Company Overview - Kingman Minerals Ltd. is focused on precious metals exploration and development in North America, with its flagship project being the historic Rosebud Mine in Arizona [9][10].

Core Viewpoint - Viewbix Inc. has entered into agreements for the sale of approximately $4.5 million shares of common stock and pre-funded warrants, aiming to explore new business opportunities and investments in various sectors [1][2][4]. Group 1: Transaction Details - The company will issue a total of 925,923 units, with common units priced at $4.86 each and pre-funded units priced similarly, minus a pre-funded warrant exercise price of $0.0001 [3]. - Each unit consists of one share of common stock and one common warrant, with an exercise price of $4.74 per share, valid for 5.5 years from issuance [3]. - The closing of the private placement is expected around July 14, 2025, pending customary closing conditions, with gross proceeds anticipated to be approximately $4.5 million before fees and expenses [4]. Group 2: Use of Proceeds - The net proceeds from the offering, along with existing cash, will be utilized for general corporate purposes and working capital [4]. Group 3: Company Overview - Viewbix operates in digital advertising through subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., focusing on search and digital content [7]. - The search segment develops software solutions for automating, optimizing, and monetizing internet campaigns, while the digital content segment creates and edits content for various target audiences to generate revenue from major advertising platforms [7].

 July 11, 2025 – TheNewswire - Vancouver, BC - Baru Gold Corp (BARU: TSX.V | BARUF: OTCQB) (“Baru” and its subsidiary PT. Tambang Mas Sangihe (“TMS”) or the “Company”) announces that further to its news release regarding the non-brokered private placement dated July 9, 2025, the Company is increasing the offer to up to 15,294,118 units priced at $0.085 per unit for total proceeds of $1,300,000 (the “Private Placement”).  The funding will support working capital and particular pre-production expenses, enabl ...

Core Viewpoint - Revival Gold Inc. has announced a strategic placement with EMR Capital Management Limited, which will result in a significant cash injection of US$10 million to support the company's gold production initiatives [1][3]. Group 1: EMR Strategic Placement - EMR will purchase 28,506,250 common shares at a price of C$0.48 per share, totaling gross proceeds of US$10 million (C$13.68 million) [1]. - EMR's pro-forma interest in Revival Gold is expected to be approximately 10.86% upon closing, assuming full subscription of the Concurrent Offering [2]. - EMR will receive customary anti-dilution rights and the right to nominate a director to the Board of Directors of Revival Gold [2]. Group 2: Concurrent Offering - Revival Gold plans to complete a non-brokered private placement of up to C$10.32 million by issuing up to 21,493,750 common shares at the same price of C$0.48 per share [4]. - The proceeds from both the EMR Strategic Placement and the Concurrent Offering will be used for the exploration and development of the Mercur and Beartrack-Arnett projects, as well as for general working capital [6]. Group 3: Regulatory and Closing Conditions - The offerings are subject to customary closing conditions, including necessary regulatory approvals, with expected closing around July 29, 2025 [8]. - Common shares issued under the Concurrent Offering will be offered to purchasers in Canada and may also be issued to purchasers outside Canada, including the United States, under applicable regulatory requirements [5]. Group 4: Company Overview - Revival Gold is one of the largest pure gold mine developers in the United States, focusing on the Mercur Gold Project in Utah and the Beartrack-Arnett Gold Project in Idaho [13].

Core Points - Mullen Group Ltd. has successfully closed a private placement of approximately CAD$400 million in senior secured notes due July 10, 2037 [1][2] - The notes consist of US$50 million with a yield of 6.91% per annum and CAD$325 million with a yield of 6.04% per annum, guaranteed by subsidiaries and secured by a first-ranking charge over the corporation's assets [2][3] - The net proceeds from the offering will be used to prepay existing private placement debt maturing in October 2026 and for general corporate purposes [2] Company Overview - Mullen Group is a public company with a significant portfolio in the transportation and logistics industries, providing a wide range of services including less-than-truckload, customs brokerage, and specialized hauling [5] - The company operates a network of independently operated businesses and offers specialized services related to energy, mining, forestry, and construction in western Canada [5] - Mullen Group is listed on the Toronto Stock Exchange under the symbol "MTL" [6]

Core Viewpoint - SeaStar Medical Holding Corporation has announced a definitive agreement for the issuance and sale of 5,242,464 shares of common stock at a price of $0.763 per share, along with unregistered warrants to purchase an equal number of shares at an exercise price of $0.638, aiming to raise approximately $4 million for general corporate purposes [1][2]. Group 1: Offering Details - The offering includes a registered direct offering priced at-the-market under Nasdaq rules and a concurrent private placement for unregistered warrants [1][2]. - The gross proceeds from the offering are expected to be around $4 million, with net proceeds intended for general corporate purposes, including working capital and capital expenditures [2]. Group 2: Regulatory and Compliance Information - The shares are being offered under a shelf registration statement previously filed with the SEC, which became effective on December 22, 2023 [3]. - The unregistered warrants are not registered under the Securities Act and cannot be sold in the U.S. without an effective registration statement or applicable exemption [4]. Group 3: Company Overview - SeaStar Medical is focused on transforming treatments for critically ill patients facing organ failure, with its first product, QUELIMMUNE, approved by the FDA in 2024 for life-threatening acute kidney injury in pediatric patients [6]. - The company’s Selective Cytopheretic Device therapy has received Breakthrough Device Designation for six therapeutic indications, indicating a potential for expedited approval processes [6]. - SeaStar is conducting a pivotal trial of its SCD therapy in adult patients with acute kidney injury, a condition affecting over 200,000 adults in the U.S. annually [6].

Core Viewpoint - Bessor Minerals Inc. has successfully completed a non-brokered private placement, raising $100,000 through the issuance of 5,000,000 common shares at a price of $0.02 per share [1][2] Group 1: Private Placement Details - The private placement was announced on May 16, 2025, and completed on July 9, 2025, with all securities subject to a four-month hold period [1][2] - The net proceeds from the private placement will be allocated for potential exploration of Bessor's properties, future acquisitions, and general working capital [2] - The private placement utilized available prospectus exemptions under securities laws, including the accredited investor exemption [2] Group 2: Regulatory Compliance - The issuance of 350,000 common shares was made to Zygmunt Hancyk, a director of Bessor, which was compliant with MI 61-101 regulations [3] - Bessor relied on specific exemptions from formal valuation and minority approval requirements due to its listing status on the TSX Venture Exchange [4] - No special committee was formed for the private placement, and the Board of Directors unanimously approved the transaction [5] Group 3: Project Updates - Bessor has terminated its option to earn a 60% interest in the Easter Gold Project located in Lincoln County, Nevada [6] - The company focuses on the exploration and development of the Redhill volcanogenic massive sulphide deposit in British Columbia [7]